ANKS1A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.584600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.909000E-01
Normal-vs-Stage2
4.111800E-01
Normal-vs-Stage3
2.360400E-02
Normal-vs-Stage4
5.830800E-01
Stage1-vs-Stage2
9.305800E-01
Stage1-vs-Stage3
7.155700E-02
Stage1-vs-Stage4
1.256560E-01
Stage2-vs-Stage3
3.950700E-04
Stage2-vs-Stage4
9.091600E-02
Stage3-vs-Stage4
7.700700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.310000E-01
Normal-vs-AfricanAmerican
8.323200E-01
Normal-vs-Asian
5.667400E-01
Caucasian-vs-AfricanAmerican
3.067800E-01
Caucasian-vs-Asian
6.136600E-01
AfricanAmerican-vs-Asian
6.227600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.296200E-01
Normal-vs-Female
4.059200E-01
Male-vs-Female
9.281400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.784600E-01
Normal-vs-Age(41-60Yrs)
3.829200E-01
Normal-vs-Age(61-80Yrs)
3.755200E-01
Normal-vs-Age(81-100Yrs)
3.343600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.219600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.638000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.864400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.113400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.610000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.221400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.419250E-01
Normal-vs-Daily Drinker
4.901400E-03
Normal-vs-Weekly Drinker
2.912800E-01
Normal-vs-Occasional Drinker
2.531200E-01
Normal-vs-Social Drinker
8.645000E-01
Non Drinker-vs-Daily Drinker
5.270300E-02
Non Drinker-vs-Weekly Drinker
8.180600E-01
Non Drinker-vs-Occasional Drinker
3.149400E-01
Non Drinker-vs-Social Drinker
3.004000E-01
Daily Drinker-vs-Weekly Drinker
1.254960E-01
Daily Drinker-vs-Occasional Drinker
2.382500E-03
Daily Drinker-vs-Social Drinker
7.988400E-02
Weekly Drinker-vs-Occasional Drinker
5.754200E-01
Weekly Drinker-vs-Social Drinker
3.950600E-01
Occasional Drinker-vs-Social Drinker
5.462200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.912750E-01
Normal-vs-Grade 2
1.032810E-01
Normal-vs-Grade 3
3.050200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.747000E-01
Grade 1-vs-Grade 3
8.481200E-01
Grade 1-vs-Grade 4
1.912750E-01
Grade 2-vs-Grade 3
7.479200E-01
Grade 2-vs-Grade 4
1.032810E-01
Grade 3-vs-Grade 4
3.050200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.065800E-01
Normal-vs-NonDiabetic
2.073000E-01
Diabetic-vs-NonDiabetic
9.962400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.203400E-01
Normal-vs-NoPancreatitis
1.684170E-01
Pancreatitis-vs-NoPancreatitis
5.303400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.685200E-01
Normal-vs-N1
4.024000E-01
N0-vs-N1
5.958200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.978800E-01
Normal-vs-TP53-NonMutant
6.777400E-01
TP53-Mutant-vs-TP53-NonMutant
6.581200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
